Hillenbrand Announces Sale of Red Valve Business to DeZURIK, Inc.
Hillenbrand, Inc. (NYSE: HI) has finalized the sale of its Red Valve business to DeZURIK, Inc. for an enterprise value of $63 million, comprising $58 million in cash and a $5 million note. This decision aligns with Hillenbrand's strategy to enhance shareholder value by concentrating on key business platforms. The company intends to use the proceeds from this sale primarily for deleveraging purposes. Financial guidance will be updated during the fiscal first quarter 2021 earnings call.
- Successfully sold Red Valve for $63 million, enhancing financial flexibility.
- Proceeds will be used for deleveraging, improving overall financial health.
- None.
BATESVILLE, Ind., Jan. 4, 2021 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: HI) announced today that it has completed the sale of its Red Valve business to DeZURIK, Inc. (DeZURIK). The sale follows Hillenbrand's previously announced intent to exit the business.
Hillenbrand entered into a Stock Purchase Agreement with DeZURIK, pursuant to which DeZURIK acquired Red Valve on December 31, 2020, at an enterprise value of
"We are excited to announce the sale of the Red Valve business, which is in line with our commitment to driving shareholder value by focusing on our key business platforms," said Joe Raver, President and CEO of Hillenbrand. "The timely divestiture of Red Valve results in increased financial flexibility and enhances overall shareholder value."
Consistent with its current capital allocation priorities, Hillenbrand intends to use proceeds from the sale primarily for deleveraging.
Delphi Advisors served as Hillenbrand's financial advisor on the divestiture.
Hillenbrand plans to update its financial guidance to reflect the sale of Red Valve on its fiscal first quarter 2021 earnings call.
About Hillenbrand
Hillenbrand (www.hillenbrand.com) is a global diversified industrial company with businesses that serve a wide variety of industries around the world. We pursue profitable growth and robust cash generation to drive increased value for our shareholders. Hillenbrand's portfolio includes industrial businesses such as Coperion, Milacron Injection Molding & Extrusion, and Mold-Masters, in addition to Batesville, a recognized leader in the death care industry in North America. Hillenbrand is publicly traded on the NYSE under "HI."
Forward-Looking Statements
Throughout this release, we make a number of "forward-looking statements" that are within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, and that are intended to be covered by the safe harbor provided under these sections. As the words imply, these are statements about future sales, earnings, cash flow, results of operations, uses of cash, financings, share repurchases, ability to meet deleveraging goals, and other measures of financial performance or potential future plans or events, strategies, objectives, beliefs, prospects, assumptions, expectations, and projected costs or savings or transactions of the Company that might or might not happen in the future, as contrasted with historical information. Forward-looking statements are based on assumptions that we believe are reasonable, but by their very nature are subject to a wide range of risks. If our assumptions prove inaccurate or unknown risks and uncertainties materialize, actual results could vary materially from Hillenbrand's (the "Company") expectations and projections.
Words that could indicate that we are making forward-looking statements include the following:
intend | believe | plan | expect | may | goal | would | project | ||||||||||||||||
become | pursue | estimate | will | forecast | continue | could | anticipate | ||||||||||||||||
target | impact | promise | improve | progress | potential | should | encourage | ||||||||||||||||
This is not an exhaustive list, but is intended to give you an idea of how we try to identify forward-looking statements. The absence of any of these words, however, does not mean that the statement is not forward-looking.
Here is the key point: Forward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements. Any number of factors, many of which are beyond our control, could cause our performance to differ significantly from what is described in the forward-looking statements. These factors include, but are not limited to: the impact of contagious diseases such as the COVID-19 pandemic and the societal, governmental, and individual responses thereto, including supply chain disruption, loss of contracts and/or customers, erosion of some customers' credit quality, downgrades of the Company's credit quality, closure or temporary interruption of the Company's or suppliers' manufacturing facilities, travel, shipping and logistical disruptions, loss of human capital or personnel, and general economic calamities; risks that the integration of Milacron disrupts current operations or poses potential difficulties in employee retention or otherwise affects financial or operating results; the ability to recognize the benefits of the acquisition of Milacron or any other acquisition or disposition, including potential synergies and cost savings or the failure of the Company or any acquired company to achieve its plans and objectives generally; impairment charges to goodwill and other identifiable intangible assets; the risk of business disruptions associated with information technology, cyber-attacks, or catastrophic losses affecting infrastructure; competition in the industries in which we operate, including on price or from nontraditional sources in the death care industry; impacts of decreases in demand or changes in technological advances, laws, or regulation on the revenues that we derive from the plastics industry; our reliance upon employees, agents, and business partners to comply with laws in many countries and jurisdictions; the impact of the significant amount of indebtedness of the Company and its ability to meet its de-leveraging goals; the ability of the Company to comply with financial or other covenants in its debt agreements; global market and economic conditions, including those related to the financial markets; our level of international sales and operations; cyclical demand for industrial capital goods; continued fluctuations in mortality rates and increased cremations; the dependence of our business units on relationships with several large customers and providers; the impact to the Company's effective tax rate of changes in the mix of earnings or tax laws and certain other tax-related matters; involvement in claims, lawsuits and governmental proceedings related to operations; uncertainty in the United States political environment or global trade policy; adverse foreign currency fluctuations; increased costs or unavailability of raw materials or certain outsourced services; labor disruptions; increasing competition for highly skilled and talented workers; and the effect of certain provisions of the Company's governing documents and Indiana law that could decrease the trading price of the Company's common stock. Shareholders, potential investors, and other readers are urged to consider these risks and uncertainties in evaluating forward-looking statements and are cautioned not to place undue reliance on the forward-looking statements. For a more in-depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in Part I, Item 1A of Hillenbrand's Form 10-K for the year ended September 30, 2020, filed with the Securities and Exchange Commission ("SEC") on November 12, 2020. The forward-looking information in this release speaks only as of the date hereof, and we assume no obligation to update or revise any forward-looking information.
View original content to download multimedia:http://www.prnewswire.com/news-releases/hillenbrand-announces-sale-of-red-valve-business-to-dezurik-inc-301200170.html
SOURCE Hillenbrand, Inc.
FAQ
What is the enterprise value of the Red Valve business sold by Hillenbrand?
What will Hillenbrand do with the proceeds from the Red Valve sale?
When did Hillenbrand announce the sale of its Red Valve business?
Who acquired Hillenbrand's Red Valve business?
What financial metrics will Hillenbrand update regarding the Red Valve sale?
